SABBY MANAGEMENT LLC 13D and 13G filings for Cocrystal Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-02 09:53 am Sale | 2023-12-31 | 13G | Cocrystal Pharma, Inc. COCP | SABBY MANAGEMENT LLC | 0 0.000% | -420,710 (Position Closed) | Filing |
| 2023-01-10 11:40 am Sale | 2022-12-31 | 13G | Cocrystal Pharma, Inc. COCP | SABBY MANAGEMENT LLC | 420,710 11.000% | -57,467 (-12.02%) | Filing |
| 2022-01-03 9:47 pm Sale | 2021-12-31 | 13G | Cocrystal Pharma, Inc. COCP | SABBY MANAGEMENT LLC | 478,177 11.000% | -333,490 (-41.09%) | Filing |
| 2021-05-12 2:13 pm Purchase | 2021-05-05 | 13G | Cocrystal Pharma, Inc. COCP | SABBY MANAGEMENT LLC | 811,667 11.000% | 811,667 (New Position) | Filing |
| 2021-01-05 09:26 am Sale | 2020-12-31 | 13G | Cocrystal Pharma, Inc. COCP | SABBY MANAGEMENT LLC | 0 0.000% | -288,462 (Position Closed) | Filing |
| 2020-02-27 11:57 am Purchase | 2020-02-27 | 13G | Cocrystal Pharma, Inc. COCP | SABBY MANAGEMENT LLC | 288,462 11.000% | 288,462 (New Position) | Filing |